Warning: This security is no longer trading.
Company has filed for Chapter 11 bankruptcy and will sell substantially all of its assets for $250M
Aralez Pharmaceuticals Inc. (ARLZ): Price and Financial Metrics
ARLZ Price/Volume Stats
| Current price | $0.03 | 52-week high | $2.98 |
| Prev. close | $0.04 | 52-week low | $0.03 |
| Day low | $0.03 | Volume | 6,765,800 |
| Day high | $0.04 | Avg. volume | 1,607,334 |
| 50-day MA | $0.30 | Dividend yield | N/A |
| 200-day MA | $1.15 | Market Cap | 2.02M |
ARLZ Stock Price Chart Interactive Chart >
Aralez Pharmaceuticals Inc. (ARLZ) Company Bio
Aralez Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada, Ireland, and the United States. The company engages in acquiring, developing, and commercializing products primarily in cardiovascular disease, pain/inflammation, and dermatology areas; and gastrointestinal, womens health, and other nonprescription products. The company is based in Milton, Canada.
ARLZ Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...